Aggressive Variant Prostate CarcinomaФаза 2NCT07218666
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
Zanzalintinib
52 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Prostate52 studies
Aggressive Variant Prostate CarcinomaФаза 2NCT07218666
Zanzalintinib
Prostate Cancer (Adenocarcinoma)Фаза 2NCT06844383
Talazoparib with enzalutamide, Talazoparib
Advanced Prostate CancerФаза 2NCT06369246
Stereotactic Body Radiation Therapy
Castration-Resistant Prostate CarcinomaPhase 1NCT05805371
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
Prostate CancerФаза 2NCT07644598
Microboost SBRT, Whole gland de-escalation 30 Gy, Whole gland de-escalation 35 Gy
Metastatic Castration-Resistant Prostate CancerФаза 2NCT06842498
FG-3246
Prostate CancerФаза 2NCT04812366
Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab, Docetaxel
Prostate Cancer PatientsФаза 2NCT07751159
Standard of Care HDR Brachytherapy, SBRT
Prostate AdenocarcinomaФаза 2NCT05832086
Fasting Mimicking Diet (FMD), Standard Anti-Cancer Diet
Prostate AdenocarcinomaФаза 2NCT07364071
Radiation therapy
Castration-Resistant Prostate CarcinomaФаза 2NCT06039371
Biopsy Procedure, Biospecimen Collection, Bone Scan, Carboplatin
Recurrent Castration-Sensitive Prostate CarcinomaФаза 2NCT06378866Papers
Abiraterone, Apalutamide, Biospecimen Collection, Bone Scan
Prostate AdenocarcinomaФаза 2NCT06067269
Apalutamide, Biospecimen Collection, Computed Tomography, Gallium Ga 68 Gozetotide
Castration Resistant Metastatic Prostate CancerФаза 2NCT04363164
Testosterone cypionate, Enzalutamide, Testosterone enanthate
Prostate CancerPhase 1/2NCT06066437Papers
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
Prostate CancerФаза 2NCT05568550
Pembrolizumab, Olaparib, Androgen Deprivation Therapy, Radiation Therapy
Metastatic Castration-Resistant Prostate CarcinomaФаза 2NCT06526299
Biospecimen Collection, Bone Scan, Computed Tomography, Lutetium Lu 177 Vipivotide Tetraxetan
Prostate AdenocarcinomaФаза 2NCT04175431
Positron Emission Tomography, Lymphadenectomy, Radiation Therapy, Abiraterone Acetate
Prostate CancerФаза 2NCT07313241
Prostate Fossa Radiotherapy, Pelvic nodal Radiotherapy, Androgen Deprivation Therapy (ADT)
Metastatic Castration-resistant Prostate CancerФаза 2NCT06568562
XL092
Metastatic Castration-resistant Prostate CancerФаза 2NCT06533644
Partial Oncolysis, SV-102
Prostate CarcinomaФаза 2NCT04947254
Abiraterone Acetate, Antiandrogen Therapy, Apalutamide, Biopsy
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Фаза 2NCT07216248
relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix + ARPI.
Prostate CancerФаза 2NCT07635238
MR-guided Stereotactic Body Radiation Therapy